期刊文献+

泮托拉唑联合格拉司琼预防含顺铂方案化疗所致恶心呕吐的疗效 被引量:2

Efficacy of Pantoprazole Combined with Granisetron in Prevention of Nausea and Vomiting induced by Cisplatin-based Chemotherapy
下载PDF
导出
摘要 目的探讨泮托拉唑联合格拉司琼、地塞米松预防含顺铂方案化疗所致恶心呕吐的临床疗效和不良反应。方法将108例行化疗的恶性肿瘤患者按随机数字表法随机分为2组:A组和B组,每组54例。2组化疗方案均采用顺铂60~75mg.m-2+生理盐水500mL静脉滴注,第1天。21d为1个疗程,完成2个疗程的化疗。2组预防恶心呕吐:A组化疗时,第1个疗程采用泮托拉唑注射液40mg+生理盐水100mL化疗前30min静脉滴注,1次.d-1,第1-3天;格拉司琼注射液3mg+生理盐水10mL化疗前30min静脉注射,1次.d-1,第1-3天;地塞米松注射液5mg+生理盐水100mL化疗前30min静脉滴注,1次.d-1,第1-3天。化疗第2个疗程采用西米替丁800mg+生理盐水100mL化疗前30min静脉滴注,1次.d-1,第1-3天。B组化疗时,第1个疗程采用西米替丁800mg+生理盐水100mL化疗前30min静脉滴注,1次.d-1,第1-3天;格拉司琼注射液3mg+生理盐水10mL化疗前30min静脉注射,1次.d-1,第1-3天;地塞米松注射液5mg+生理盐水100mL化疗前30min静脉滴注,1次.d-1,第1-3天。化疗第2个疗程采用泮托拉唑注射液40mg+生理盐水100mL化疗前30min静脉滴注,1次.d-1,第1-3天。观察2组患者的临床疗效及不良反应(头痛、头晕、乏力、腹痛、腹泻、口干、失眠)。结果 A组总有效率明显高于B组(P<0.05)。A组头痛、头晕及乏力、腹痛、腹泻、口干、失眠发生率与B组比较差异均无统计学意义(均P>0.05)。结论泮托拉唑联合格拉司琼、地塞米松预防含顺铂方案化疗所致恶心呕吐有较好的疗效。 Objective To explore the clinical curative effect and adverse reactions of pantoprazole combined with granisetron and dexamethasone in the prevention of nausea and vomiting induced by cisplatin-based chemotherapy.Methods A total of 108 cancer patients undergoing chemotherapy were randomly divided into group A and group B,with 54 patients in each group.All patients received two courses of cisplatin-based chemotherapy(21 days per course).Cisplatin 60-75 mg·m-2 diluted in 500 mL of physiological saline was administered by intravenous infusion on day 1.For the prevention of nausea and vomiting,patients in group A were intravenously infused with pantoprazole 40 mg in 100 mL of physiological saline,granisetron 3 mg in 10 mL of physiological saline and dexamethasone 5 mg in 100 mL of physiological saline 30 minutes before chemotherapy once per day within the first 3 days during the first treatment course,followed by cimetidine 800 mg in 100 mL of physiological saline 30 minutes before chemotherapy once per day within the first 3 days during the second treatment course.Patients in group B were intravenously infused with cimetidine 800 mg in 100 mL of physiological saline,granisetron 3 mg in 10 mL of physiological saline and dexamethasone 5 mg in 100 mL of physiological saline 30 minutes before chemotherapy once per day within the first 3 days during the first treatment course,followed by pantoprazole 40 mg in 100 mL of physiological saline 30 minutes before chemotherapy once per day within the first 3 days during the second treatment course.Clinical curative effects and adverse reactions(headache,dizziness,fatigue,stomachache,diarrhoea,dry mouth and insomnia) were observed in both groups.Results The total effective rate in group A was significantly higher than that in group B(P<0.05).No obvious differences in adverse reactions were found between the two groups(P>0.05).Conclusion Pantoprazole combined with granisetron and dexamethasone is effective for the prevention of nausea and vomiting induced by cisplatin-based chemotherapy.
出处 《南昌大学学报(医学版)》 CAS 2012年第12期70-72,75,共4页 Journal of Nanchang University:Medical Sciences
关键词 泮托拉唑 格拉司琼 西米替丁 顺铂 恶心 呕吐 pantoprazole granisetron cimetidine cisplatin nausea vomiting
  • 相关文献

参考文献10

  • 1马剑,韩正祥.化疗引起的恶心呕吐机制研究进展及其对策[J].徐州医学院学报,2010,30(9):627-630. 被引量:53
  • 2张晓静,张频.肿瘤化疗所致恶心呕吐的发生机制和药物治疗的研究进展[J].癌症进展,2006,4(4):348-354. 被引量:128
  • 3杜力,江春玲.泮托拉唑联合托烷司琼治疗化疗所致消化道反应的疗效观察[J].中国社区医师(医学专业),2011,13(36):140-141. 被引量:3
  • 4Tomek R,Vrdoljak E,Vrbanec D. Croatian guideliness for prevention of chemotherapy induced nausea and vomiting[J].Lijecnicki Vjesnik,2009,(3/4):49-53.
  • 5黄仁宝,周晋华,李春颖.联合止吐方案预防顺铂所致恶心呕吐的临床观察[J].安徽医学,2011,32(11):1837-1838. 被引量:4
  • 6Zech K,Steinijans V W,Huber R. Pharmacokinetics and drug interactions-relevant factors for the choice of a drug[J].International Journal of Clinical Pharmacology and Therapeutics,1996,(S 1):S3-S6.
  • 7Blumen H. The interaction between PPI and orthr drugs[J].Drug Safety,2006,(09):769-771.
  • 8Vrabel M. Is ondansetron more effective than granisetron for chemotherapy-induced nausea and vomiting?A review of comparative trials[J].Clinical Journal of Oncology Nursing,2007,(06):809-813.doi:10.1188/07.CJON.809-813.
  • 9Saito M,Aogi K,Sekine I. Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy:a double-blind,double-dummy,randomised,comparative phase Ⅲ trial[J].Lancet Oncology,2009,(02):115-124.
  • 10Yeo W,Mo F K,Suen J J. A randomized study of aprepitant,ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy[J].Breast Cancer Research and Treatment,2009,(03):529-535.doi:10.1007/s10549-008-9957-9.

二级参考文献68

  • 1赵忠斌,魏振平,芮伟.化疗止吐临床治疗药物新进展[J].世界临床药物,2006,27(8):480-484. 被引量:35
  • 2陈文彬.诊断学[M].7版.北京:人民卫生出版社,2008:35-37.
  • 3[1]Wiser W,Berger A.Practical management of chemotherapy-induced nausea and vomiting.Oncology Williston Park),2005,19:637
  • 4[2]Aapro M,et al.Palonosetron is effective in preventing acute and delayed chemotherapy-induced nausea and vomiting in patients recieving highly emetogenic chemotherapy (HEC)[Abstract].Support Care Cancer,2003,11:A17
  • 5[3]Jordan K,Kasper C,Schmoll HJ.Chemotherapy-induced nausea and vomiting:Current and new standards in the antiemetic prophylaxis and treatment.Eur J Cancer,2005,41:199
  • 6[4]Roila F,Donati D,Tamberi S,et al.Delayed emesis:Incidence,pattern,prognostic factors and optimal treatment.Support Care Cancer,2002,10:88
  • 7[5]website:http//www.mascc.org.Multinational association for supportive care in cancer.Consensus Conference on antiemitic therapy Perugia,2004,March 29-31
  • 8[6]Hesketh PJ,Kris MG,Grunberg SM,et al.Proposal for classifying the acute emetogenicity of cancer chemotherapy.J Clin Oncol,1997,15:103
  • 9[7]Morrow GR.The effect of a susceptibility to motion sickness on the side effects of cancer chemotherapy.Cancer,1985,55:2766
  • 10[8]Osoba D,Zee B,Pater J,et al.Determinants of postchemotherapy nausea and vomiting in patients with cancer.Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials Group.J Clin Oncol,1997,15:116

共引文献177

同被引文献30

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部